GLP-1 class · Consultation first
Semaglutide Pathway Review
About Semaglutide Pathway Review
Are Ozempic or Wegovy the right weight loss solution for your individual health profile and goals? The Semaglutide Pathway Review at Yoyime Clinic in Dubai is a thorough, doctor-led assessment for adults considering treatment with semaglutide, a clinically proven GLP-1 receptor agonist that regulates appetite, satiety, gastric emptying, insulin secretion and glucose metabolism for meaningful, sustainable weight reduction. Our doctor will evaluate your medical history, BMI, obesity-related conditions and current medications before recommending the most clinically appropriate formulation, with treatment recommendations remaining entirely brand-neutral and based solely on suitability. As a DHA and MOHAP regulated prescription therapy, every semaglutide treatment at Yoyime Clinic is supported by structured dose titration, regular clinical review and personalized lifestyle guidance throughout.
Benefits of Semaglutide Pathway Review
Assess Ozempic Or Wegovy Suitability
Explains Benefits And Risks
Supports Personalized Dose Titration
Not Recommended for Patients
Who Are Pregnant
With MEN2 History
With Semaglutide Allergy
Step-by-Step Procedure - Semaglutide Pathway Review
Book Your Pathway Review
Schedule a Semaglutide (Ozempic® & Wegovy®) Pathway Review at Yoyime Clinic before commencing semaglutide treatment.
Comprehensive Clinical Assessment
Our doctor reviews your medical history, BMI, weight trajectory, obesity-related medical conditions, previous weight-management strategies, current medications, allergies and family history to assess whether semaglutide is appropriate.
Eligibility & Safety Screening
Potential contraindications, risk factors and treatment suitability are evaluated. Where clinically appropriate, laboratory investigations may be recommended to assess metabolic health and support safe prescribing.
Semaglutide Education
Our doctors will explain how Ozempic® and Wegovy® work, discuss their similarities and differences, review expected weight-loss outcomes, explain the gradual dose-escalation schedule and discuss possible side effects and their management.
Personalised Treatment Recommendation
Based on your clinical assessment, your doctor determines whether semaglutide therapy is appropriate, whether further investigations are required or whether an alternative weight-management pathway would be more suitable.
Ongoing Monitoring & Lifestyle Support
If treatment begins, you will receive structured clinical follow-up, dose optimisation and personalised nutrition and lifestyle guidance to support sustainable weight management and long-term treatment success.
Have questions about Semaglutide Pathway Review?
Message our team on WhatsApp for personalised guidance before you book.
- Highly specialised and focused treatment techniques
- Personalised care by DHA certified professionals
- Comfort-driven experience with proven results
- Safe, convenient and effective
Frequently Asked Questions
Semaglutide Pathway Review
The Semaglutide Pathway Review at Yoyime Clinic is a doctor-led consultation that evaluates whether treatment with semaglutide is appropriate. It includes clinical assessment, eligibility screening, patient education and personalised treatment planning before any prescription is issued.
Semaglutide is a GLP-1 receptor agonist that mimics the body's natural GLP-1 hormone. It helps regulate appetite, slows gastric emptying, improves satiety and supports healthy glucose regulation, making it an effective option for medically supervised weight management in appropriate patients.
Both Ozempic® and Wegovy® contain semaglutide as their active ingredient. However, Ozempic® was developed primarily for adults with type 2 diabetes, while Wegovy® is approved specifically for chronic weight management and is prescribed using a higher maintenance dose. Our doctor will determine which option is most appropriate based on individual clinical needs.
No. At Yoyime Clinic, treatment decisions are brand-neutral. The recommendation is based on patient medical history, treatment goals, clinical eligibility and the approved indication of each medication rather than preference for a particular brand.
The pathway is intended for adults with overweight or obesity who may benefit from medically supervised weight management. Eligibility depends on factors such as BMI, obesity-related health conditions, previous weight-loss attempts, current medications and overall health.
Depending on medical history and clinical assessment, our doctors may recommend laboratory investigations to evaluate blood sugar control, metabolic health, thyroid function, liver and kidney function or other biomarkers before treatment begins.
The most frequently reported side effects include nausea, vomiting, constipation, diarrhoea, abdominal discomfort and reduced appetite, particularly during dose escalation. A doctor will explain how these effects are monitored and managed throughout treatment.
Semaglutide treatment follows a structured dose-escalation schedule, beginning with a lower dose before gradually increasing over several weeks. This helps improve tolerability, reduces gastrointestinal side effects and allows the body to adapt safely to the medication.
If semaglutide is not the most appropriate treatment option, Yoyime Clinic doctors will discuss alternative evidence-based weight management pathways based on patients medical assessment and treatment goals.
Yes. Medication is only one part of successful weight management. Yoyime Clinic can incorporate nutritional guidance and lifestyle support to help improve dietary habits, preserve lean muscle mass and promote sustainable long-term results.
Once treatment begins, Yoyime Clinic provides ongoing clinical follow-up to monitor weight-loss progress, treatment response, side effects and dose optimisation thus ensuring your programme remains safe, effective and tailored to your individual needs.
At Yoyime Clinic, semaglutide therapy begins with a comprehensive medical assessment rather than a prescription alone. Our doctor-led pathway combines personalised eligibility screening, evidence-based treatment selection, structured dose titration and ongoing clinical monitoring to ensure Ozempic® or Wegovy® is prescribed safely and integrated into a comprehensive, long-term weight management programme.
